Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.
Ishihara L; Warren L; Gibson R; Amouri R; Lesage S; Dürr A; Tazir M; Wszolek ZK; Uitti RJ; Nichols WC; Griffith A; Hattori N; Leppert D; Watts R; Zabetian CP; Foroud TM; Farrer MJ; Brice A; Middleton L; Hentati F; Archives Of Neurology, 2006, vol. 63, issue 9, p 1250, ISSN 00039942. ISBN 00039942.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef